180 related articles for article (PubMed ID: 20349215)
1. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.
Lin F; Zheng SE; Shen Z; Tang LN; Chen P; Sun YJ; Zhao H; Yao Y
Med Oncol; 2011 Jun; 28(2):649-53. PubMed ID: 20349215
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis.
Oda Y; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Yokoyama R; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 May; 19(5):738-45. PubMed ID: 16528367
[TBL] [Abstract][Full Text] [Related]
3. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Lu CL; Ji Y; Ge D; Guo J; Ding JY
Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
[TBL] [Abstract][Full Text] [Related]
4. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
[TBL] [Abstract][Full Text] [Related]
5. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.
Rastogi S; Kumar R; Sankineani SR; Marimuthu K; Rijal L; Prakash S; Jalan D; Khan SA; Sharma MC
Int Orthop; 2012 Nov; 36(11):2315-21. PubMed ID: 23015149
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
7. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
Wu H; Zhang J; Dai R; Xu J; Feng H
J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
[TBL] [Abstract][Full Text] [Related]
8. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
[TBL] [Abstract][Full Text] [Related]
10. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma.
Lammli J; Fan M; Rosenthal HG; Patni M; Rinehart E; Vergara G; Ablah E; Wooley PH; Lucas G; Yang SY
Int Orthop; 2012 Nov; 36(11):2307-13. PubMed ID: 22855059
[TBL] [Abstract][Full Text] [Related]
11. Investigating the Relationship between of Vascular Endothelial Growth Factor and HER-2neu in IHC Staining with Metastasis and Mortality in Patients with Osteosarcoma.
Aznab M; Khajevand Ahmady M; Jamshidi K; Madani SH; Khazaei S; Shoushtaryzadeh T; Bagheri A
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3005-3009. PubMed ID: 33112560
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
14. Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.
Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH
Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796
[TBL] [Abstract][Full Text] [Related]
15. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.
Guan G; Zhang Y; Lu Y; Liu L; Shi D; Wen Y; Yang L; Ma Q; Liu T; Zhu X; Qiu X; Zhou Y
Cancer Lett; 2015 Feb; 357(1):254-264. PubMed ID: 25444927
[TBL] [Abstract][Full Text] [Related]
16. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
18. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.
Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956
[TBL] [Abstract][Full Text] [Related]
19. Expression of molecular markers in the tumor and survival prognosis in osteosarcoma.
Boulytcheva IV; Soloviev YN; Kushlinskii NE; Mahson AN
Bull Exp Biol Med; 2010 Dec; 150(2):237-42. PubMed ID: 21240382
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas.
Mardani A; Gheytanchi E; Mousavie SH; Madjd Jabari Z; Shooshtarizadeh T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):67-73. PubMed ID: 31983166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
